These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3914816)

  • 1. Gastric inhibitory polypeptide (GIP): a therapeutic possibility?
    Moody AJ; Jones IR; Krarup T; Owens DR; Saurbrey N
    Acta Paediatr Scand Suppl; 1985; 320():66-71. PubMed ID: 3914816
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
    Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
    Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus.
    Krarup T; Saurbrey N; Moody AJ; Kühl C; Madsbad S
    Metabolism; 1987 Jul; 36(7):677-82. PubMed ID: 3298936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state.
    Amland PF; Jorde R; Aanderud S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1985 Apr; 20(3):315-20. PubMed ID: 3890139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S; Regeur L; Faber OK; Tronier B
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
    Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
    Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric inhibitory polypeptide (GIP) response in diabetes using a highly specific antiserum.
    Alam MJ; Kerr JI; Cormican K; Buchanan KD
    Diabet Med; 1992 Jul; 9(6):542-5. PubMed ID: 1643802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
    Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
    Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
    Meneilly GS; Bryer-Ash M; Elahi D
    Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.
    Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
    Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5.
    Ternand C; Go VL; Gerich JE; Haymond MW
    J Pediatr; 1982 Jul; 101(1):36-9. PubMed ID: 7045315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.